Detection of abnormal karyotypes by prenatal diagnostic indications.

Figshare2025-05-20 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Detection_of_abnormal_karyotypes_by_prenatal_diagnostic_indications_/29112679 数据链接链接失效反馈

官方服务：

资源简介：

Detection of abnormal karyotypes by prenatal diagnostic indications.

创建时间：

2025-05-20

Test No. 483: Mammalian Spermatogonial Chromosomal Aberration Test

生殖细胞突变

染色体异常

This test measures structural chromosomal aberrations (both chromosome- and chromatid-type) in dividing spermatogonial germ cells and is, therefore, expected to be predictive of induction of heritable

Organisation for Economic Co-operation and Development90

Table2_A retrospective single-center analysis of prenatal diagnosis and follow-up of 626 chinese patients with positive non-invasive prenatal screening results.doc

产前基因诊断

染色体异常

This study explored the diagnostic efficiency of different prenatal diagnostic approaches for women with positive non-invasive prenatal screening (NIPS) results by analyzing their clinical information

NIAID Data Ecosystem80

Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier

植入前遗传学诊断

染色体异常

Objective: To prove the ability to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. Design: Case report. Setting: Academic center for reproductive medicine.

NIAID Data Ecosystem40

Chromosomal status of GM00285 and GM05563 fibroblast and iPSCs. Homo sapiens

染色体异常

干细胞基因组学

We generated induced pluripotent stem cells (iPSCs) from ring chromosome patients' cells. To examine chromosomal status in these iPSCs, we performed SNP microarray analysis using Agilent Sureprint G3

NIAID Data Ecosystem90

Comparison of clinical outcomes from baseline analysis of the two screening approaches in a general screening population.

筛查评估

染色体异常

NIPT, non-invasive prenatal testing * 70% of total affected pregnancies (30% receive no screening). † Assuming termination rates for trisomy 21, trisomy 18, trisomy 13, and monosomy X of 87%, 81%, 90%

NIAID Data Ecosystem40

Detection of abnormal karyotypes by prenatal diagnostic indications.

资源简介：

相关数据集